May 26, 2020
Nordic Nanovector ASA: Results for the First Quarter 2020
Media
May 22, 2020
Oncopeptides completes enrollment to the pivotal phase 3 study OCEAN for relapsed refractory multiple myeloma – 450 patients included
May 21, 2020
Carisma Therapeutics to Present and Meet with Potential Investors at Upcoming Healthcare Investor Conferences
May 20, 2020
Bulletin from the Annual General Meeting of Vicore Pharma Holding AB (publ)
May 20, 2020
Strongbridge Biopharma plc Announces $30 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
May 20, 2020
Nordic Nanovector ASA: Notice of Annual General Meeting on 10 June 2020
May 19, 2020
Report from Orexo AB’s extraordinary general meeting, 19 May 2020
May 19, 2020
Bulletin from the annual shareholders’ meeting in BONESUPPORT HOLDING AB on 19 May 2020
May 19, 2020
Nordic Nanovector ASA: Invitation to First Quarter 2020 Results Webcast
May 18, 2020
Orexo and Lyfebulb Partner During Unprecedented Times to Help Those Struggling with Alcohol and Opioid Use Disorders
